| Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784) |
|---|
| 08/25/2004 | EP1448215A2 Use of laminarin in the treatment of cancer as well as bacterial, viral and fungal infections |
| 08/25/2004 | EP1448192A2 Novel methods of treating local fungal and bacterial infections |
| 08/25/2004 | EP1448186A1 Medicament for the treatment of viral skin and tumour diseases |
| 08/25/2004 | EP1448174A2 Water soluble nanoparticles of hydrophilic and hydrophobic active materials |
| 08/25/2004 | EP1448151A1 Dosage form, device and methods of treatment |
| 08/25/2004 | EP1448127A1 Compositions for the treatment of infectious diseases |
| 08/25/2004 | EP1448056A2 Surfactant protein d for the prevention and diagnosis of pulmonary emphysema |
| 08/25/2004 | EP1448052A1 Anti-pathogenic composition useful in blood preservation |
| 08/25/2004 | EP1366048B1 Pyrazolopyridine derivatives |
| 08/25/2004 | EP1343764B1 Urea and urethane derivatives as integrin inhibitors |
| 08/25/2004 | EP1299132B1 Limiting the presence of microorganisms using polymer-bound metal-containing compositions |
| 08/25/2004 | EP1228235B1 Method for transfer of molecular substances with prokaryontic nucleic acid-binding proteins |
| 08/25/2004 | EP1200457B1 Cysteine protease inhibitors |
| 08/25/2004 | EP1198245B1 Use of purified invaplex from gram negative bacteria as a vaccine |
| 08/25/2004 | EP1190257B1 Early detection of flaviviruses using the ns1 glycoprotein |
| 08/25/2004 | EP1169337B1 Steroid nitrates for the treatment of oxidative injury and endothelial dysfunction |
| 08/25/2004 | EP1140162B1 Vaccination method for efficient induction of cytotoxic t lymphocyte response |
| 08/25/2004 | EP1086080B1 Diarylselenide compounds and their use in human or veterinary medicine and in cosmetics |
| 08/25/2004 | EP1083881B1 LIPOSOME COMPOSITIONs containing a quinolone derivative AND their use as antibacterial agents |
| 08/25/2004 | EP1077719B1 Vaccine delivery system based on gonococcal blebosomes |
| 08/25/2004 | EP1064018B1 The use of isolated domains of type iv collagen to modify cell and tissue interactions |
| 08/25/2004 | EP0922092B1 Method of attenuating viruses |
| 08/25/2004 | EP0836619B1 Purification of dalbaheptide antibiotics by isoelectric focusing |
| 08/25/2004 | EP0833903B1 Multivalent bovine coronavirus vaccine and method of treating bovine coronavirus infection |
| 08/25/2004 | EP0830130B1 Tnf-alpha converting enzyme |
| 08/25/2004 | CN1524123A A soluble complex comprising a retroviral surface glycoprotein |
| 08/25/2004 | CN1524088A A virus causing respiratory tract illness in susceptible mammals |
| 08/25/2004 | CN1524085A Oligose ,sulfating product and oligose cluster and its uses |
| 08/25/2004 | CN1524082A Beta-amino tetrahydroimidazo (1,2-a) pyrazines and ahydrotrioazolo (4,3-a) pyrazines as dipeptidyl idase inhibitors for the treatment or prevention of diabetes |
| 08/25/2004 | CN1524080A Phthalatyinone-piperidino-derivatives as pde4 inhibitors |
| 08/25/2004 | CN1524079A Novel sulfamides and their use as endothelin receptor antagonists |
| 08/25/2004 | CN1524003A Composition for topical administration comprising an interleukin-2 inhibitor and an antimicrobial agent |
| 08/25/2004 | CN1523995A Preventives and/or remedies for fish infections |
| 08/25/2004 | CN1523981A A pharmaceutical tablet having a high API content |
| 08/25/2004 | CN1523979A Pharmaceutical compositions of adsorbates of amorphous drug |
| 08/25/2004 | CN1523103A Pseudorabies TK*/gE*/gI* gene dificiency mark live vaccine and preparation method thereof |
| 08/25/2004 | CN1523041A Bulgaria inquinans polysaccharide, method for preparing the same and pharmaceutical composition using the compound as active component |
| 08/25/2004 | CN1523040A Fusion protein of human thymosin alpha1 and human composite interferon and preparation thereof |
| 08/25/2004 | CN1523028A Novel phosphonate-nucleotide compound |
| 08/25/2004 | CN1523026A Process for producing sulbactam valeryl oxygen methyl ester |
| 08/25/2004 | CN1522761A Composite hepatitis B vaccine for treatment and its preparation method |
| 08/25/2004 | CN1522760A Bivalent gene engineering vaccine of fowl infectious bursal disease and pasteurellosis |
| 08/25/2004 | CN1522759A Interferon and synergist combined pharmaceutical |
| 08/25/2004 | CN1522758A Topical compound interferon preparation |
| 08/25/2004 | CN1522754A Extraction of antiviral immune matter for curing sexual disorder and its formulation |
| 08/25/2004 | CN1522749A Atypical pneumonia therapeutic drug |
| 08/25/2004 | CN1522741A Tinea liquid medicine and its preparation method |
| 08/25/2004 | CN1522726A Novel schisandra fruit soft capsule formulation and its preparation method |
| 08/25/2004 | CN1522725A Health care beverage |
| 08/25/2004 | CN1522722A Flu and prostatitis preventing and curing medicine, and method for making same |
| 08/25/2004 | CN1522698A Antivirals |
| 08/25/2004 | CN1163754C Method for diagnosing a patient for chlamydia |
| 08/25/2004 | CN1163602C Fusion protein of tubercle bacillus antigen, and its use |
| 08/25/2004 | CN1163496C Vinyl-pyrrolidone cynnematin with alkali subtituent |
| 08/25/2004 | CN1163494C Carbapenem derivative, use thereof and intermediate compound of the same |
| 08/25/2004 | CN1163484C 4-Aroyl-Piperidin-CCR-3 receptor antagonist III |
| 08/25/2004 | CN1163272C Application of TNF antagonists as medicaments for treating septic diseases |
| 08/25/2004 | CN1163271C Synthetic peptide vaccine of influenzand its preparing process |
| 08/25/2004 | CN1163270C Modified meningococcal polysacharide conjugate vaccines |
| 08/25/2004 | CN1163264C Pharmaceutical compositions |
| 08/25/2004 | CN1163250C External application medicine for treating sweaty feet with bromidrosis |
| 08/25/2004 | CN1163235C Antiviral linear polymer |
| 08/25/2004 | CN1163234C Composite biocidal particles |
| 08/25/2004 | CN1163229C Chemical graft anti-gonococcus medicinal soluble cotton yarn, and it preparation method |
| 08/25/2004 | CN1163218C Skin-protecting cosmetics |
| 08/24/2004 | US6780890 Contacting s-adenosylhomocysteine (sah with a luxs protein whereby s- adenosylhomocysteine undergoes conversion to autoinducer-2 |
| 08/24/2004 | US6780873 Urea substituted imidazoquinolines |
| 08/24/2004 | US6780870 Treatment of the pain (both chronic and acute), fever and inflammation of a variety of conditions and diseases mediated by cox-2 |
| 08/24/2004 | US6780869 Selective inhibitor of cox-2; antiinflammatory agent |
| 08/24/2004 | US6780858 Hydroxyamidines and related compounds |
| 08/24/2004 | US6780849 Nitric-oxide releasing lipid molecules selected from phosphoglycerides, lipids having a sphingosine base as a backbone, a monoglyceride, a diglyceride, a glycosylacylglycerol and a sterol containing s-n=o, n-n=o or |
| 08/24/2004 | US6780847 Nucleotide sequences coding polypeptide for use in the treatment and prevention of viral infections |
| 08/24/2004 | US6780836 Treating infection or ischemic wound in a mammal by administering relaxin, a hormone which induces secretion of vascular endothelial growth factor (vegf) |
| 08/24/2004 | US6780630 Comprises live and inactivated vaccines; immunogens; for human and animal infants |
| 08/24/2004 | US6780628 Enzyme treatment |
| 08/24/2004 | US6780624 Glycosyltransferases for biosynthesis of oligosaccharides, and genes encoding them |
| 08/24/2004 | US6780616 By cultivation of streptomyces |
| 08/24/2004 | US6780442 Efficient method for producing compositions enriched in anthocyanins |
| 08/24/2004 | US6780421 Vaccine composition comprising at least one antigen and adjuvanting amount of 3-beta-(n-(n',n'-dimethylaminoethane)carbamoyl) cholesterol |
| 08/24/2004 | US6780419 Isolated polypeptide comprising specified amino acid sequence or immunogenic fragment of at least 15 contiguous amino acids, which when administered to subject induces antibody or t-cell mediated immune response that recognizes polypeptide |
| 08/24/2004 | US6780414 Methods of identifying bacterial genes that are incompatible with bacterial pathogenicity, and the use of such genes, such as cada, to reduce pathogenicity in a bacteria or to combat pathogenic bacterial infections |
| 08/24/2004 | US6780400 Delivery of antiemetics through an inhalation route |
| 08/24/2004 | US6780399 Delivery of stimulants through an inhalation route |
| 08/24/2004 | US6780324 Preparation of sterile stabilized nanodispersions |
| 08/24/2004 | CA2143610C Use of norastemizole for the treatment of allergic disorders |
| 08/24/2004 | CA2116355C Infectious bovine rhinotracheitis virus mutants and vaccines |
| 08/19/2004 | WO2004070002A2 Cell lines and host nucleic acid sequences related to infectious disease |
| 08/19/2004 | WO2004069998A2 Oxindole derivatives as antimicrobial agents |
| 08/19/2004 | WO2004069876A2 Trimeric polypeptide construct to induce an enduring t cell response |
| 08/19/2004 | WO2004069873A2 Antigen/antibody or ligand/receptor glycosylated specificity exchangers |
| 08/19/2004 | WO2004069864A1 Polypeptides f' of the hepatitis c virus, epitopes, and the diagnostic and therapeutic applications thereof |
| 08/19/2004 | WO2004069863A2 Constrained hiv v3 loop peptides as immunogens and receptor antagonists |
| 08/19/2004 | WO2004069856A1 Process for preparing inhibitors of nucleoside phosphorylases and nucleosidases |
| 08/19/2004 | WO2004069855A1 Novel glycosyl transferase with consideration of activity expression mechanism and method of producing the same |
| 08/19/2004 | WO2004069854A1 Novel anhydrolide derivatives having antibacterial activity |
| 08/19/2004 | WO2004069839A1 Carbapenem derivative |
| 08/19/2004 | WO2004069834A1 Tricyclic compound, process for producing the same, and use |
| 08/19/2004 | WO2004069833A1 Fused-ring pyridine derivative, process for producing the same, and use |
| 08/19/2004 | WO2004069832A2 Antibacterial agents |
| 08/19/2004 | WO2004069816A1 Oxazolidinone derivatives as antimicrobials |